$TGTX Anyone want to discuss their ublituximab CD20? I believe this is derived from goats (spun-out from former Genzyme company): Since then, GTC has worked on an undisclosed new use for ATryn. It licensed a compound called ublituximab to TG Therapeutics Inc. as a possible treatment for cancer and autoimmune diseases. http://www.telegram.com/article/20120325/NEWS/103259992/1002/RSS01&source=rss